弘元綠能(603185.SH):子公司簽署《合作經營協議》
格隆匯7月8日丨弘元綠能(603185.SH)公佈,2025年7月7日,控股子公司弘元光能(無錫)有限公司(以下簡稱“弘元光能”)與江蘇順風光電科技有限公司(以下簡稱“順風光電”)簽署了《合作經營協議》。公司將與順風光電下屬無錫尚德太陽能電力有限公司(以下簡稱“無錫尚德”)等子公司合作開展生產經營管理,以幫助順風光電維持無錫尚德的穩定運營。同時,順風光電與廈門建發新興能源有限公司前期簽訂的《合作經營協議》同步終止。
2025年5月26日,無錫市新吳區人民法院作出對無錫尚德進行預重整的決定。公司有意向作爲投資人蔘與無錫尚德的預重整事項,本次協議的簽署旨在維護預重整期間的穩定運營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.